Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session
Liminatus Pharma, Inc. (NASDAQ: LIMN ) shares are trending on Wednesday night. Shares of the California-based immuno-oncology biotechnology company jumped 30.49% to $0.15 in after-hours trading after Liminatus amended and restated its merger agreement with InnocsAI LLC, a cell-therapy developer. Revised Structure Fast